Atom | Blueprint Neurotherapeutics Network (BPN): Biologic-based Drug Discovery and Development for Disorders of the Nervous System (U44 Clinical Trial Optional)

Funder: National Institutes of Health

Funding Amounts: Budgets are not limited but typically up to $500,000/year (Phase I, max 2 years) and $1,500,000/year (Phase II, max 3 years); total project period up to 5 years.

Summary: Supports small businesses in developing biologic-based therapies for nervous system disorders, from lead optimization through Phase 1 clinical trials.

Key Information: Only U.S. small businesses are eligible; projects must focus on biologics (not small molecules); NIH provides access to contract research resources and consultants.

Blueprint Neurotherapeutics Network (BPN): Biologic-based Drug Discovery and Development for Disorders of the Nervous System (U44 Clinical Trial Optional)

Sign in to see full grant listing